Product logins

Find logins to all Clarivate products below.


Urological Devices | Market Insights | Latin America (Supplemental) | 2025

Driven by the increasing prevalence of urethral stones, aging population, product innovation, and patient awareness of urological treatments in this region, the Latin American urological device market will continue to expand through 2033. Furthermore, favorable demographic trends, an increasing prevalence of BPH and prostate cancer cases, declining ASPs supporting the adoption among budget constraint facilities, and increasing patient awareness and physician training will support urological procedure volume growth. Moreover, the rising trend for minimally invasive procedures, as these techniques not only provide improved efficacy but also reduced postoperative pain and shorter recovery periods, will result in increased adoption of associated devices.

Related Medtech Insights Reports

Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Trauma Devices – Market Insights – Latin America
The Latin American trauma device market is positioned for strong growth, driven by the rapid expansion of highvolume product segments, a growing aging population, and increasingly favorable…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…